Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
78 hedge funds and large institutions have $28.1M invested in Tetraphase Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 29 reducing their positions, and 16 closing their positions.
257% more call options, than puts
Call options by funds: $107K | Put options by funds: $30K
5% more capital invested
Capital invested by funds: $26.8M → $28.1M (+$1.36M)
9% less funds holding
Funds holding: 86 → 78 (-8)
41% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 29
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.58M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$223K |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$127K |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$127K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$90K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.09M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$794K |
| 3 |
JP Morgan Chase
New York
|
-$783K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$380K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$299K |
TTPH Hedge Fund Activity: Q1 2019 in Review
78 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2019, worth a combined $28.1M — up 5.1% from $26.8M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of TTPH and 8 opened new positions — a net loss of 8 holders — while 29 trimmed existing stakes and 17 added.
The largest buyer was Vanguard Group, adding an estimated $1.58M. The largest seller was Deutsche Bank, cutting an estimated $1.09M.
- 78 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2019, down from 86 in Q4 2018.
- Funds reported $28.1M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2019, up 5.1% quarter-over-quarter.
- 8 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2019 and 16 closed out, a net change of -8 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $1.58M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2019 was Deutsche Bank, an estimated $1.09M sold.
Based on aggregated 13F filings for Q1 2019.